875 results on '"Olin, Jeffrey W."'
Search Results
2. Genome-wide association meta-analysis of spontaneous coronary artery dissection identifies risk variants and genes related to artery integrity and tissue-mediated coagulation
3. Unusual Vascular Diseases of the Extremities
4. Thromboangiitis Obliterans (Buerger's Disease)
5. Author Correction: Genetic investigation of fibromuscular dysplasia identifies risk loci and shared genetics with common cardiovascular diseases
6. Evaluation and Treatment of Patients With Lower Extremity Peripheral Artery Disease Consensus Definitions From Peripheral Academic Research Consortium (PARC)
7. Genetic investigation of fibromuscular dysplasia identifies risk loci and shared genetics with common cardiovascular diseases
8. 2021 ACC/AHA/SVM/ACP Advanced Training Statement on Vascular Medicine (Revision of the 2004 ACC/ACP/SCAI/SVMB/SVS Clinical Competence Statement on Vascular Medicine and Catheter-Based Peripheral Vascular Interventions): A Report of the ACC Competency Management Committee
9. Fibromuscular Dysplasia: Contemporary Concepts and Future Directions
10. The Ongoing Odyssey of Renal Denervation
11. Updates in Spontaneous Coronary Artery Dissection
12. Abstract 14653: Genome-wide Association Study of Peripheral Artery Disease and Critical Limb Ischemia Identifies Novel Genetic Loci and Coagulation Pathways
13. Pathologic Disparities Between Peripheral Artery Disease and Coronary Artery Disease
14. Letter by Kadian-Dodov and Olin Regarding Article, “Embolic Stroke of Undetermined Source and Symptomatic Nonstenotic Carotid Disease”
15. UNDER PRESSURE: UTILIZING ULTRASOUND GUIDED COMPRESSION FOR TREATMENT OF FEMORAL ARTERY PSEUDOANEURYSM IN A NEWBORN WITH CONGENITAL HEART DISEASE
16. Effect of Physical Activity Assessment on Prognostication for Peripheral Artery Disease and Mortality
17. ACC/AHA Aortic Disease Guidelines
18. First international consensus on the diagnosis and management of fibromuscular dysplasia
19. Paclitaxel-Mortality Risk Hypothesis Debunked: What We Learned and How It Will Change Future Clinical Trials.
20. Spontaneous Coronary Artery Dissection
21. Usefulness of the Addition of Beta-2-Microglobulin, Cystatin C and C-Reactive Protein to an Established Risk Factors Model to Improve Mortality Risk Prediction in Patients Undergoing Coronary Angiography
22. Thromboangiitis Obliterans (Buerger’s Disease)
23. Renal Artery Disease
24. Expanding Clinical Phenotype of Fibromuscular Dysplasia
25. Prevalence of Intracranial Aneurysm in Women With Fibromuscular Dysplasia: A Report From the US Registry for Fibromuscular Dysplasia
26. 2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
27. 2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
28. Genetic determinants of the ankle-brachial index: A meta-analysis of a cardiovascular candidate gene 50K SNP panel in the candidate gene association resource (CARe) consortium
29. Inflammatory Diseases of the Aorta
30. Current progress in clinical, molecular, and genetic aspects of adult fibromuscular dysplasia.
31. Author Correction: Genetic investigation of fibromuscular dysplasia identifies risk loci and shared genetics with common cardiovascular diseases.
32. ACCF/AHA/ACR/SCAI/SIR/SVM/SVN/SVS 2010 performance measures for adults with peripheral artery disease: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures, the American College of Radiology, the Society for Cardiac Angiography and Interventions, the Society for Interventional Radiology, the Society for Vascular Medicine, the Society for Vascular Nursing, and the Society for Vascular Surgery (Writing Committee to Develop Clinical Performance Measures for Peripheral Artery Disease)
33. Remembering Jess R Young, MD, MSVM (1928–2021): SVM Founding Member and First President
34. Angioplasty to Treat Pulmonary Hypertension in Takayasu Arteritis
35. sj-pdf-2-vmj-10.1177_1358863X20987551 – Supplemental material for 2021 ACC/AHA/SVM/ACP Advanced Training Statement on Vascular Medicine (Revision of the 2004 ACC/ACP/SCAI/SVMB/SVS Clinical Competence Statement on Vascular Medicine and Catheter-Based Peripheral Vascular Interventions)
36. sj-pdf-1-vmj-10.1177_1358863X20987551 – Supplemental material for 2021 ACC/AHA/SVM/ACP Advanced Training Statement on Vascular Medicine (Revision of the 2004 ACC/ACP/SCAI/SVMB/SVS Clinical Competence Statement on Vascular Medicine and Catheter-Based Peripheral Vascular Interventions)
37. Safety and Efficacy of Renal Artery Stenting Following Suboptimal Renal Angioplasty for De Novo and Restenotic Ostial Lesions: Results from a Nonrandomized, Prospective Multicenter Registry
38. Peripheral Artery Disease: Current Insight Into the Disease and Its Diagnosis and Management
39. Cardiovascular manifestations of hypermobile Ehlers–Danlos syndrome and hypermobility spectrum disorders
40. Unsupervised Learning for Automated Detection of Coronary Artery Disease Subgroups
41. Spontaneous compartment syndrome and endovascular repair of tibioperoneal trunk pseudoaneurysm in Ehlers-Danlos syndrome
42. Diagnostic utility of carotid artery duplex ultrasonography in the evaluation of syncope: a good test ordered for the wrong reason
43. Combined Role of Reduced Estimated Glomerular Filtration Rate and Microalbuminuria on the Prevalence of Peripheral Arterial Disease
44. Abstract 14032: Racial Differences in Clinical Manifestations and Events in Fibromuscular Dysplasia: A Report of the United States Registry for FMD
45. Efficacy and Safety of Vorapaxar by Intensity of Background Lipid‐Lowering Therapy in Patients With Peripheral Artery Disease: Insights From the TRA2P‐TIMI 50 Trial
46. Association of Fibromuscular Dysplasia and Pulsatile Tinnitus: A Report of the US Registry for Fibromuscular Dysplasia
47. 2011 ACCF/AHA focused update of the guideline for the management of patients with peripheral artery disease (Updating the 2005 guideline): A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society for Vascular Medicine, and Society for Vascular Surgery
48. Peripheral artery disease. Part 2: medical and endovascular treatment
49. Peripheral artery disease. Part 1: clinical evaluation and noninvasive diagnosis
50. Elevated osteoprotegerin is associated with abnormal ankle brachial indices in patients infected with HIV: a cross‐sectional study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.